Drugs News and Research

RSS

New analysis method could pave the way for important breakthroughs in immunotherapy

In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.

11 Dec 2020

Genetic differences play a vital role in early diagnosis of Alzheimer's disease

The two clinically used methods for detecting amyloid pathology in Alzheimer's disease do not give unambiguous results, with the risk of incorrect or delayed care interventions.

11 Dec 2020

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and Technology have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA).

11 Dec 2020

Researchers use AI platform to identify best combination of available therapies against COVID-19.

A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.

11 Dec 2020

A new model for assessing kidney function in cancer patients

Cold Spring Harbor Laboratory scientists have developed a new model for assessing kidney function in cancer patients as part of an international collaboration that involved contributions from the United Kingdom and Sweden.

10 Dec 2020

MUSC cancer researcher named as a 2020 fellow of National Academy of Innovators

In recognition of her spirit of innovation and the lasting impact of her work on cancer patients, MUSC Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., has been named as a 2020 fellow of the National Academy of Innovators, the organization announced Dec. 8.

10 Dec 2020

New computer algorithm could end misidentification of cancer cells in laboratories

Researchers from the University of Kent have developed a computer algorithm that can identify differences in cancer cell lines based on microscopic images, a unique development towards ending misidentification of cells in laboratories.

10 Dec 2020

Using AI to find optimal combination of available therapies against SARS-CoV-2

A team of researchers from the National University of Singapore has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.

10 Dec 2020

Antiepileptic drug reduces early signs of clinical dysfunction in people with ALS

The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.

10 Dec 2020

Fan therapy may offer relief for patients with advanced cancer experiencing breathlessness

Blowing air from a fan into the face of patients with advanced cancer experiencing breathlessness, and other nonpharmacologic interventions, may offer symptom relief, according to new research directed by Johns Hopkins Kimmel Cancer Center investigators.

10 Dec 2020

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Now, a study on the utility of hydroxychloroquine as prophylaxis against COVID-19, has been released in the latest issue of Annals of Internal Medicine.

10 Dec 2020

MEDS433 hinders SARS-CoV-2 replication

A paper that recently appeared in the preprint server bioRxiv* reports the powerful activity of a compound named MEDS433 against this virus.

10 Dec 2020

UVA researchers identify genes that influence risk for common form of heart disease

Researchers at the University of Virginia have shed light on how our genes affect our risk for coronary artery disease, the most common form of heart disease.

10 Dec 2020

Cancer Research UK announces dramatic cuts to its life-saving research budget

Cancer Research UK have announced today further dramatic cuts, slashing £45 million from its research budget.

10 Dec 2020

FDA approves first COVID-19 direct-to-consumer test

Today, the U.S. Food and Drug Administration authorized LabCorp's Pixel COVID-19 Test Home Collection Kit for use by any individual 18 years and older without a prescription.

9 Dec 2020

New consortium aims to understand principles underlying the formation of coronaviruses

The University of California, Riverside, is the recipient of a 2021 UC Multicampus Research Programs and Initiatives, or MRPI, award allowing the campus to put together a UC Coronavirus Assembly Research Consortium.

9 Dec 2020

Mastectomy and reconstructive surgery may increase risk of becoming persistent drug users

Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the risk of developing persistent use of opioids and sedative-hypnotic drugs, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.

9 Dec 2020

Drugs News and Research

New analysis method could pave the way for important breakthroughs in immunotherapy

Genetic differences play a vital role in early diagnosis of Alzheimer's disease

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Researchers use AI platform to identify best combination of available therapies against COVID-19.

A new model for assessing kidney function in cancer patients

MUSC cancer researcher named as a 2020 fellow of National Academy of Innovators

New computer algorithm could end misidentification of cancer cells in laboratories

Using AI to find optimal combination of available therapies against SARS-CoV-2

Antiepileptic drug reduces early signs of clinical dysfunction in people with ALS

Fan therapy may offer relief for patients with advanced cancer experiencing breathlessness

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

MEDS433 hinders SARS-CoV-2 replication

UVA researchers identify genes that influence risk for common form of heart disease

Cancer Research UK announces dramatic cuts to its life-saving research budget

FDA approves first COVID-19 direct-to-consumer test

New consortium aims to understand principles underlying the formation of coronaviruses

Mastectomy and reconstructive surgery may increase risk of becoming persistent drug users

Tomatoes could become a new, natural source of Parkinson's disease drug

Neutrophils may play a key role in COVID-19-related thrombosis

Scientists identify two drug candidates that counteract deficiencies caused by lack of MECP2 gene

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News